Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0RX6D
|
|||
| Drug Name |
3-acylidene-2-oxoindole derivative 1
|
|||
| Synonyms |
PMID26560530-Compound-29
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Company |
NUMERATE, INC. THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY GRIFFIN, John RAIMUNDO, Brian MADRID, Peter KHOSLA, Chaitan JIN, Xi KLOECK, Cornelius
|
|||
| Structure |
 |
Download2D MOL |
||
| Formula |
C21H13ClN2O2
|
|||
| Canonical SMILES |
C1=CC=C(C=C1)N2C3=C(C(=CC=C3)Cl)C(=CC(=O)C4=CN=CC=C4)C2=O
|
|||
| InChI |
1S/C21H13ClN2O2/c22-17-9-4-10-18-20(17)16(12-19(25)14-6-5-11-23-13-14)21(26)24(18)15-7-2-1-3-8-15/h1-13H/b16-12+
|
|||
| InChIKey |
MAXLUMXHDRQNGJ-FOWTUZBSSA-N
|
|||
| PubChem Compound ID | ||||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Tissue transglutaminase (TG2) | Target Info | Inhibitor | [1] |
| Target's Patent Info | Tissue transglutaminase (TG2) | Target's Patent Info | [1] | |
| KEGG Pathway | Huntington's disease | |||
| Pathway Interaction Database | Beta1 integrin cell surface interactions | |||
| Thromboxane A2 receptor signaling | ||||
| Alpha9 beta1 integrin signaling events | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Transglutaminase inhibitors: a patent review.Expert Opin Ther Pat. 2016;26(1):49-63. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.